title: Membrane insertion by anthrax protective antigen in cultured cells.
abstract: The enzymatic moieties of anthrax toxin enter the cytosol of mammalian cells via a pore in the endosomal membrane formed by the protective antigen (PA) moiety. Pore formation involves an acidic pH-induced conformational rearrangement of a heptameric precursor (the prepore), in which the seven 2beta2-2beta3 loops interact to generate a 14-strand transmembrane beta-barrel. To investigate this model in vivo, we labeled PA with the fluorophore 7-nitrobenz-2-oxa-1,3-diazole (NBD) at cysteine residues introduced into the 2beta2-2beta3 loop. Each labeled PA was bound to CHO cells, and NBD fluorescence was monitored over time in stirred cell suspensions or by confocal microscopy. A strong increase was observed with NBD at positions 305, 307, 309, and 311, sites where side chains are predicted to face the bilayer, and little change was seen at residues 304, 306, 308, 310, and 312, sites where side chains are predicted to face the pore lumen. The increase at position 305 was inhibited by membrane-restricted quenchers, low temperature, or various reagents known to affect toxin action. Of the 24 NBD attachment sites examined, all but three gave results qualitatively consistent with the beta-barrel model. Besides supporting the beta-barrel model of membrane insertion, our results describe the time course of insertion and identify PA residues where NBD gives a strong signal upon membrane insertion in vivo.
authors.affiliation: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, Massachusetts 02115, USA.
authors.forename: Maen
authors.initials: M
authors.lastname: Qa'dan
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Christensen
authors.forename: Lei
authors.initials: L
authors.lastname: Zhang
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Roberts
authors.forename: R John
authors.initials: RJ
authors.lastname: Collier
mesh_terms: D009327:4-Chloro-7-nitrobenzofurazan; D000818:Animals; D000942:Antigens, Bacterial / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D001408:Bacillus anthracis / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D001427:Bacterial Toxins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D016466:CHO Cells; D002462:Cell Membrane / Q000378:metabolism*; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D003545:Cysteine / Q000737:chemistry; D004926:Escherichia coli / Q000235:genetics; D005453:Fluorescence; D005456:Fluorescent Dyes; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D007700:Kinetics; D008051:Lipid Bilayers / Q000737:chemistry; D018613:Microscopy, Confocal; D008954:Models, Biological; D009154:Mutation; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary
chemical_list: D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D005456:Fluorescent Dyes; D007202:Indicators and Reagents; D008051:Lipid Bilayers; C030325:anthrax toxin; D009327:4-Chloro-7-nitrobenzofurazan; D003545:Cysteine